Nicholas Piramal India Inks R&D Deal With Merck
This article was originally published in PharmAsia News
Executive Summary
Mumbai-based Nicholas Piramal India Limited inked a research and development deal with Delhi-based Merck subsidiary MSD Pharmaceuticals, NPIL announced Nov. 19